erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
schneider said that he is hoping to conduct a subsequent study of 15 to 20 pregnancies and that he is encouraged by these results..